CARBOPLATIN AUC DOSING IN PAEDIATRIC PATIENTS: INFLUENCE OF GLOMERULAR FILTRATION RATE MEASUREMENT
5PSQ-152
REAL-WORLD EFFICACY AND COST DATA ON PATIENTS WITH METASTATIC NON-SMALL CELL LUNG CANCER TREATED WITH CHECKPOINT INHIBITORS IN AN ITALIAN UNIVERSITY HOSPITAL IN SEPTEMBER 2016-2020
5PSQ-151
SEVERE TOXICITY IN A PATIENT WITH ACUTE LYMPHOBLASTIC LEUKAEMIA RESULTING FROM SUBSTITUTION OF DAUNORUBICIN WITH DOXORUBICIN DUE TO MEDICINE SHORTAGE: A CASE REPORT
5PSQ-150
DISSEMINATED INTRAVASCULAR COAGULATION AFTER PD-1 BLOCKADE WITH NIVOLUMAB IN ADVANCED MELANOMA: A CASE REPORT
5PSQ-149
DRUGE INTERACTION IN BREAST CANCER TRIPLE NEGATIVE THERAPY: DOCETAXEL AND FLUVOXAMINE. A CASE REPORT
5PSQ-148
IMPROVING SAFETY IN THE VACCINE CIRCUIT
5PSQ-147
IMMUNOGLOBULIN SHORTAGE : PRACTICE MODIFICATIONS AND CLINICAL OUTCOMES IN A REFERENCE CENTRE
5PSQ-146
“REAL LIFE” EFFECTIVENESS AND SAFETY ASSESSMENT OF FOSCARNET
5PSQ-144
PHARMACOTHERAPY OPTISMISATION IN PATIENTS OVER 50 YEARS OF AGE WITH HIV INFECTION: FIRST STEPS
5PSQ-143
DRUG RESISTANT TUBERCULOSIS IN A HIGH COMPLEXITY SPECIALISED UNIT: EPIDEMIOLOGY, TREATMENT AND MAIN ADVERSE REACTIONS
5PSQ-142
SAFETY OF AZOLE ANTIFUNGALS IN TRANSPLANTED PATIENTS RECEIVING TACROLIMUS
5PSQ-141
ANALYSIS OF THE CEFTAROLINE ASSOCIATED NEUTROPENIA
5PSQ-140
UNIT DOSE SYSTEM: MODEL OF IMPLEMENTATION OF THE ANTIMICROBIAL STEWARDSHIP
5PSQ-139
PRESCRIPTIVE APPROPRIATENESS OF ANTIBIOTIC THERAPIES: CRUCIAL ROLE OF THE HOSPITAL PHARMACIST
5PSQ-138
INFLUENCE OF ANTIBIOTIC STEWARDSHIP PROGRAMME INTERVENTIONS IN A HOSPITAL AT HOME UNIT
